Baxter International Inc
BAX21.070USD
+0.380+1.84%
終値 01/09, 16:00（ET）15分遅れの株価
10.83B時価総額
損失額直近12ヶ月PER
詳細情報 Baxter International Inc 企業名
Baxter International Inc. is a global medtech company. Its segments include Medical Products and Therapies, Healthcare Systems and Technologies, and Pharmaceuticals. The Medical Products and Therapies segment includes sales of its sterile IV solutions, infusion systems, administration sets, parenteral nutrition therapies and surgical hemostat, sealant, and adhesion prevention products. The Healthcare Systems and Technologies segment includes sales of its connected care solutions and collaboration tools, including smart bed systems, patient monitoring systems and diagnostic technologies, respiratory health devices, and advanced equipment for the surgical space, including operating room integration technologies, precision positioning devices, and other accessories. The Pharmaceuticals segment includes sales of specialty injectable pharmaceuticals, inhaled anesthesia, and drug compounding. It provides a portfolio of diagnostic, critical care, nutrition, hospital and surgical products.
Baxter International Incの企業情報
企業コードBAX
会社名Baxter International Inc
上場日Jun 20, 2097
最高経営責任者「CEO」Hider (Andrew P)
従業員数38000
証券種類Ordinary Share
決算期末Jun 20
本社所在地One Baxter Parkway
都市DEERFIELD
証券取引所NASDAQ OMX NASDAQ Basic NYSE
国United States of America
郵便番号60015
電話番号12249482000
ウェブサイトhttps://www.baxter.com/
企業コードBAX
上場日Jun 20, 2097
最高経営責任者「CEO」Hider (Andrew P)
Baxter International Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
368.05K
+368050.00%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-650.00%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
101.60K
-16548.00%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
35.70K
+7183.00%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+7183.00%
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Independent Director
22.94K
+7183.00%
Mr. Stephen H. (Steve) Rusckowski
Mr. Stephen H. (Steve) Rusckowski
Independent Director
Independent Director
16.45K
+7183.00%
Mr. Jeffrey A. (Jay) Craig
Mr. Jeffrey A. (Jay) Craig
Independent Director
Independent Director
10.65K
+7183.00%
Ms. Nancy M. Schlichting
Ms. Nancy M. Schlichting
Lead Independent Director
Lead Independent Director
7.97K
+7183.00%
Ms. Clare Trachtman
Ms. Clare Trachtman
Vice President, Investor Relations
Vice President, Investor Relations
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Andrew P. Hider
Mr. Andrew P. Hider
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
368.05K
+368050.00%
Dr. Jeanne K. Mason, Ph.D.
Dr. Jeanne K. Mason, Ph.D.
Chief Human Resources Officer, Executive Vice President
Chief Human Resources Officer, Executive Vice President
141.02K
-650.00%
Mr. David S. Rosenbloom
Mr. David S. Rosenbloom
Executive Vice President, General Counsel
Executive Vice President, General Counsel
101.60K
-16548.00%
Dr. Stephen N. (Steve) Oesterle, M.D.
Dr. Stephen N. (Steve) Oesterle, M.D.
Independent Director
Independent Director
35.70K
+7183.00%
Ms. Catherine R. (Cathy) Smith
Ms. Catherine R. (Cathy) Smith
Independent Director
Independent Director
30.23K
+7183.00%
Ms. Patricia B. (Patty) Morrison
Ms. Patricia B. (Patty) Morrison
Independent Director
Independent Director
22.94K
+7183.00%
収益内訳
通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
事業別USD
会社名
収益
比率
Infusion Therapies and Technologies
1.02B
36.44%
Care and Connectivity Solutions
474.00M
16.87%
Injectables and Anesthesia
332.00M
11.81%
Advanced Surgery
296.00M
10.53%
Front Line Care
293.00M
10.43%
他の
391.00M
13.91%
地域別USD
会社名
収益
比率
United States
1.54B
54.66%
International
1.27B
45.34%
事業別
地域別
事業別USD
会社名
収益
比率
Infusion Therapies and Technologies
1.02B
36.44%
Care and Connectivity Solutions
474.00M
16.87%
Injectables and Anesthesia
332.00M
11.81%
Advanced Surgery
296.00M
10.53%
Front Line Care
293.00M
10.43%
他の
391.00M
13.91%
株主
更新時刻: Mon, Nov 17
更新時刻: Mon, Nov 17
株主統計
種類
株主統計
株主統計
比率
The Vanguard Group, Inc.
12.11%
Dodge & Cox
11.17%
Pzena Investment Management, LLC
11.16%
BlackRock Institutional Trust Company, N.A.
6.09%
BlackRock Financial Management, Inc.
4.80%
他の
54.66%
株主統計
株主統計
比率
The Vanguard Group, Inc.
12.11%
Dodge & Cox
11.17%
Pzena Investment Management, LLC
11.16%
BlackRock Institutional Trust Company, N.A.
6.09%
BlackRock Financial Management, Inc.
4.80%
他の
54.66%
種類
株主統計
比率
Investment Advisor/Hedge Fund
47.20%
Investment Advisor
44.83%
Hedge Fund
2.90%
Research Firm
2.48%
Pension Fund
1.50%
Insurance Company
1.45%
Bank and Trust
1.22%
Sovereign Wealth Fund
1.14%
Individual Investor
0.45%
機関投資家保有株
更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
1745
530.97M
103.29%
-34.72M
2025Q3
1826
527.84M
110.04%
+1.85M
2025Q2
1880
509.50M
105.73%
+4.72M
2025Q1
1916
504.93M
105.92%
-38.38M
2024Q4
1965
494.73M
105.04%
+14.02M
2024Q3
1980
482.92M
103.29%
+12.67M
2024Q2
2019
470.33M
102.19%
-1.85M
2024Q1
2069
469.00M
102.47%
-52.95M
2023Q4
2111
469.21M
101.33%
+9.34M
2023Q3
2090
463.57M
98.58%
+5.62M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
The Vanguard Group, Inc.
62.26M
12.11%
+305.92K
+0.49%
Sep 30, 2025
Dodge & Cox
57.40M
11.17%
+5.27M
+10.12%
Sep 30, 2025
Pzena Investment Management, LLC
57.39M
11.16%
+1.93M
+3.48%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
31.32M
6.09%
+1.48M
+4.95%
Sep 30, 2025
BlackRock Financial Management, Inc.
24.69M
4.8%
+5.96M
+31.81%
Sep 30, 2025
State Street Investment Management (US)
22.00M
4.28%
+60.06K
+0.27%
Sep 30, 2025
T. Rowe Price Associates, Inc.
12.69M
2.47%
-8.52M
-40.17%
Sep 30, 2025
Geode Capital Management, L.L.C.
12.54M
2.44%
-345.65K
-2.68%
Sep 30, 2025
Fidelity Management & Research Company LLC
11.93M
2.32%
+7.96M
+200.31%
Sep 30, 2025
Greenhaven Associates, Inc.
10.69M
2.08%
+4.40M
+70.05%
Dec 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
iShares Large Cap Value Active ETF
2.23%
First Trust Indxx Medical Devices ETF
1.69%
Invesco Raymond James SB-1 Equity ETF
1.5%
State Street SPDR S&P Health Care Equipment ETF
1.37%
Invesco S&P 500 Equal Weight Health Care ETF
1.26%
Franklin US Dividend Booster Index ETF
1.26%
iShares U.S. Medical Devices ETF
1.13%
Invesco Zacks Multi-Asset Income ETF
0.8%
Humankind US Stock ETF
0.76%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
0.57%
詳細を見る
iShares Large Cap Value Active ETF
比率2.23%
First Trust Indxx Medical Devices ETF
比率1.69%
Invesco Raymond James SB-1 Equity ETF
比率1.5%
State Street SPDR S&P Health Care Equipment ETF
比率1.37%
Invesco S&P 500 Equal Weight Health Care ETF
比率1.26%
Franklin US Dividend Booster Index ETF
比率1.26%
iShares U.S. Medical Devices ETF
比率1.13%
Invesco Zacks Multi-Asset Income ETF
比率0.8%
Humankind US Stock ETF
比率0.76%
Pacer CFRA-Stovall Equal Weight Seasonal Rot Idx
比率0.57%
配当金
過去5年間の配当金総支払額は
2.28B
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
Nov 11, 2025
BAX.NB Final Cash Dividend of gross USD 0.01 paid on Jan 02, 2026 going ex on Nov 28, 2025 with reinvestment option
Nov 28, 2025
Jan 02, 2026
Nov 28, 2025
Jul 14, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Oct 01, 2025 going ex on Aug 29, 2025 with reinvestment option
Aug 29, 2025
Oct 01, 2025
Aug 29, 2025
May 06, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Jul 01, 2025 going ex on May 30, 2025 with reinvestment option
May 30, 2025
Jul 01, 2025
May 30, 2025
Feb 11, 2025
BAX.NB Interim Cash Dividend of gross USD 0.17 paid on Apr 01, 2025 going ex on Feb 28, 2025 with reinvestment option
Feb 28, 2025
Apr 01, 2025
Feb 28, 2025
Nov 11, 2024
BAX.NB Final Cash Dividend of gross USD 0.17 paid on Jan 02, 2025 going ex on Nov 29, 2024 with reinvestment option
Nov 29, 2024
Jan 02, 2025
Nov 29, 2024
Jul 16, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 01, 2024 going ex on Aug 30, 2024 with reinvestment option
Aug 30, 2024
Oct 01, 2024
Aug 30, 2024
May 07, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Jul 01, 2024 going ex on May 31, 2024 with reinvestment option
May 31, 2024
Jul 01, 2024
May 31, 2024
Feb 12, 2024
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Apr 01, 2024 going ex on Feb 29, 2024 with reinvestment option
Mar 01, 2024
Apr 01, 2024
Feb 29, 2024
Nov 14, 2023
BAX.NB Final Cash Dividend of gross USD 0.29 paid on Jan 02, 2024 going ex on Nov 30, 2023 with reinvestment option
Dec 01, 2023
Jan 02, 2024
Nov 30, 2023
Jul 18, 2023
BAX.NB Interim Cash Dividend of gross USD 0.29 paid on Oct 02, 2023 going ex on Aug 31, 2023 with reinvestment option
Sep 01, 2023
Oct 02, 2023
Aug 31, 2023
詳細を見る
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
よくある質問
Baxter International Incの上位5名の株主は誰ですか？
Baxter International Incの上位5名の株主は以下のとおりです。
The Vanguard Group, Inc.は62.26M株を保有しており、これは全体の12.11%に相当します。
Dodge & Coxは57.40M株を保有しており、これは全体の11.17%に相当します。
Pzena Investment Management, LLCは57.39M株を保有しており、これは全体の11.16%に相当します。
BlackRock Institutional Trust Company, N.A.は31.32M株を保有しており、これは全体の6.09%に相当します。
BlackRock Financial Management, Inc.は24.69M株を保有しており、これは全体の4.80%に相当します。
The Vanguard Group, Inc.は62.26M株を保有しており、これは全体の12.11%に相当します。
Dodge & Coxは57.40M株を保有しており、これは全体の11.17%に相当します。
Pzena Investment Management, LLCは57.39M株を保有しており、これは全体の11.16%に相当します。
BlackRock Institutional Trust Company, N.A.は31.32M株を保有しており、これは全体の6.09%に相当します。
BlackRock Financial Management, Inc.は24.69M株を保有しており、これは全体の4.80%に相当します。
Baxter International Incの株主タイプ上位3種は何ですか？
Baxter International Incの株主タイプ上位3種は、
The Vanguard Group, Inc.
Dodge & Cox
Pzena Investment Management, LLC
The Vanguard Group, Inc.
Dodge & Cox
Pzena Investment Management, LLC
Baxter International Inc（BAX）の株式を保有している機関の数はいくつですか？
2025Q4時点で、Baxter International Incの株式を保有している機関は1745社あり、保有株式の総市場価値は約530.97Mで、全体の103.29%を占めています。2025Q3と比較して、機関の持ち株は-6.75%増加しています。
Baxter International Incの最大の収益源は何ですか？
FY2025Q2において、Infusion Therapies and Technologies部門がBaxter International Incにとって最大の収益を生み出しており、その金額は1.02Bで、全収益の36.44%を占めています。
